Elise A Delagnes1, Melissa Zheng1, Annick Aubin-Pouliot2, Jolie L Chang2, William R Ryan3. 1. School of Medicine, University of California-San Francisco, San Francisco, California, U.S.A. 2. Department of Otolaryngology-Head and Neck Surgery, Salivary Gland Surgery Center, University of California-San Francisco, San Francisco, California, U.S.A. 3. Department of Otolaryngology-Head and Neck Surgery, Division of Head and Neck Oncologic and Endocrine Surgery, Salivary Gland Surgery Center, University of California-San Francisco, San Francisco, California, U.S.A.
Abstract
OBJECTIVES: To prospectively assess short-term symptom change after sialendoscopy-assisted salivary duct surgery (SASDS) for salivary duct stenosis. STUDY DESIGN: Prospective cohort study. METHODS: Patients with obstructive sialadenitis from duct stenosis completed the 20-item Chronic Obstructive Sialadenitis Symptoms (COSS) Questionnaire (scored 0-100) prior to SASDS and 3 months postoperatively. RESULTS: Thirty glands in 19 patients with endoscopically confirmed salivary duct stenosis showed overall symptom improvement, with a mean COSS score reduction of 12.9 points (standard deviation [SD] 13.1) to a mean postoperative score of 25.1 (range 0-75.5) (P < 0.001) with six (20%) glands (5 patients) achieving complete symptom resolution. Symptoms improved significantly for parotid glands (n = 20) by 16.6 points (SD 15.9) (P < 0.0001). For distal duct stenoses (n = 25), significant symptom improvement was seen in cases treated with dilation only (n = 17; partial stenoses) with a mean 20.6 point COSS reduction (SD 19.0) (P < 0.0005) and in cases treated with sialodochoplasty (n = 5; 4 complete, 1 partial stenosis) with a mean 13.8 point reduction (SD 4.7) (P < 0.005). Symptom scores did not improve after SASDS in proximal stenoses (n = 3) and distal stenoses cases not amenable to treatment (n = 3). CONCLUSION: SASDS for salivary duct stenosis often can improve obstructive salivary symptoms; however, many patients report persistent symptoms after surgery. Partial duct stenoses or distal duct stenoses are associated with the greatest improvements in COSS scores after SASDS. LEVEL OF EVIDENCE: 4. Laryngoscope, 127:2770-2776, 2017.
OBJECTIVES: To prospectively assess short-term symptom change after sialendoscopy-assisted salivary duct surgery (SASDS) for salivary duct stenosis. STUDY DESIGN: Prospective cohort study. METHODS:Patients with obstructive sialadenitis from duct stenosis completed the 20-item Chronic Obstructive Sialadenitis Symptoms (COSS) Questionnaire (scored 0-100) prior to SASDS and 3 months postoperatively. RESULTS: Thirty glands in 19 patients with endoscopically confirmed salivary duct stenosis showed overall symptom improvement, with a mean COSS score reduction of 12.9 points (standard deviation [SD] 13.1) to a mean postoperative score of 25.1 (range 0-75.5) (P < 0.001) with six (20%) glands (5 patients) achieving complete symptom resolution. Symptoms improved significantly for parotid glands (n = 20) by 16.6 points (SD 15.9) (P < 0.0001). For distal duct stenoses (n = 25), significant symptom improvement was seen in cases treated with dilation only (n = 17; partial stenoses) with a mean 20.6 point COSS reduction (SD 19.0) (P < 0.0005) and in cases treated with sialodochoplasty (n = 5; 4 complete, 1 partial stenosis) with a mean 13.8 point reduction (SD 4.7) (P < 0.005). Symptom scores did not improve after SASDS in proximal stenoses (n = 3) and distal stenoses cases not amenable to treatment (n = 3). CONCLUSION: SASDS for salivary duct stenosis often can improve obstructive salivary symptoms; however, many patients report persistent symptoms after surgery. Partial duct stenoses or distal duct stenoses are associated with the greatest improvements in COSS scores after SASDS. LEVEL OF EVIDENCE: 4. Laryngoscope, 127:2770-2776, 2017.
Authors: Fatemeh Ramazani; Amr Hamour; Caroline C Jeffery; Vincent Biron; Yaser Alrajhi; Daniel O'Connell; David W J Côté Journal: J Otolaryngol Head Neck Surg Date: 2022-02-04
Authors: Samanta Buchholzer; Frédéric Faure; Livia Tcheremissinoff; François R Herrmann; Tommaso Lombardi; Siu-Kwan Ng; Jean-Michel Lopez; Urs Borner; Robert L Witt; Robert Irvine; Olivier Abboud; Claudio R Cernea; Shirish Ghan; Takeshi Matsunobu; Zahoor Ahmad; Randall Morton; Aleksandar Anicin; Emad A Magdy; Rashid Al Abri; Iordanis Konstantinidis; Pasquale Capaccio; Hila Klein; Vincent Vander Poorten; Davide Lombardi; Bernard Lyons; Hussain Al Rand; George Liao; Jeong K Kim; Sethu Subha; Richard Y-X Su; Chin-Hui Su; Franciscus Boselie; Raphaël Andre; Jörg D Seebach; Francis Marchal Journal: Laryngoscope Date: 2021-07-08 Impact factor: 2.970